Studies from Harvard University Provide New Data on Biosimilars (Benefit Design and Biosimilar Coverage In Medicare Part D: Evidence and Implications From Recent Reforms): Drugs and Therapies – Biosimilars
2024 JUL 29 (NewsRx) -- By a
The news reporters obtained a quote from the research from
According to the news reporters, the research concluded: “Given ample evidence of a relationship between drug coverage and utilization, our results suggest that Medicare patients and the federal government could realize substantial savings if Part D formularies resembled those of employer-sponsored plans.”
This research has been peer-reviewed.
For more information on this research see: Benefit Design and Biosimilar Coverage In Medicare Part D: Evidence and Implications From Recent Reforms. Health Affairs, 2024;43(5):717-724. Health Affairs can be contacted at: Project Hope,
Our news correspondents report that additional information may be obtained by contacting
The direct object identifier (DOI) for that additional information is: https://doi.org/10.1377/hlthaff.2023.01297. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
(Our reports deliver fact-based news of research and discoveries from around the world.)
Editorial: Flood insurance remains a vexing problem
Carl Snyder, the Real Bills Doctrine, and the New York Fed in the Great Depression (Updated July 11, 2024): Social Sciences
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News